OPDIVO is a medication that has the following indications:
- as monotherapy for the treatment of advanced (unresectable or metastatic) melanoma in adults - a form of skin cancer which is not suitable for surgery
- for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) after prior chemotherapy in adults - types of lung cancer which have spread near the lungs or to other parts of the body
- as monotherapy for the treatment of advanced renal cell carcinoma after prior therapy in adults - a form of kidney cancer that has spread across the body
OPDIVO is a type of immunotherapy which means it works by boosting the immune system's ability to detect and fight disease.
Visit MacMillan Cancer Support for further information about melanoma ,non-small cell lung cancer or,renal cell carcinoma. You can also find out further information from your Healthcare Professional.